RepRegen™ Ltd. (Formerly Known as BioCeramic Therapeutics)'s Chief Science Officer, Dr. Molly Stevens, is Named One of the Top-10 Scientists Under the Age of 40 in Britain

Published: Oct 20, 2010

LONDON--(BUSINESS WIRE)--RepRegen™, the ‘smart biomaterials’ company, announced today that its Chief Science Officer, Molly Stevens, Ph.D., has been named one of the top-10 most important scientists under the age of 40 in Britain by The Times’ Eureka 100, “a new guide to the 100 most important contemporary figures in British science and engineering.”

Back to news